Menu
Menu
Effective patient selection for innovative therapies relies on high-quality biomarker testing, yet navigating evolving technologies can be challenging.
With our advanced technology, leading next-generation sequencing (NGS) diagnostic solutions, custom assay services, and global partner ecosystem for regulatory submission, you can pursue the right diagnostic path to maximize patient impact.
SOPHiA DDM™ Assay Development
SOPHiA DDM™ Clinical Trial Assay (CTA)
SOPHiA DDM™ Companion Diagnostics (CDx)
“Through this collaboration, we aim to enable the widespread application of precision medicine in oncology across Africa, and thus contributing to the improvement of patient outcomes across the African continent.
“Identifying patients with ecDNA-driven tumors is an area of high unmet medical need. We are pleased to partner with SOPHiA GENETICS, experts in developing cloud-based IVD NGS software algorithms, for the development of our ecDNA detection algorithm, ECHO, into a clinical trial device.”
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
Powered by Bioz
